Russia Develops A New Covid-19 Vaccine To Combat Omicron Variant

Moscow, Nov 30, : Russia’s Gamaleya National Research Center of Epidemiology and Microbiology announced that it has begun to develop a new version of the Sputnik Vaccine to target the Omicron Omicron variant of Covid-19.
Gamaleya stated Monday that the center is examining whether its Sputnik V or Sputnik Light vaccines are able to neutralise Omicron variants, Xinhua reported.

 Russia Develops A New Covid-19 Vaccine To Combat Omicron Variant-TeluguStop.com

The center stated that the new Sputnik Omicron version could be ready for mass production within 45 days if modifications are needed.They also hope that an enormous number of Sputnik Omicron booster shot can be introduced into international markets in the early 2022.

int/khz/
#Russia #Develops #Covid #Vaccine #Combat #Omicron

.

#Omicron #Combat #COvid #Vaccine #Russia